• Exchange: -
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

3745350 Canada Inc



3745350 Canada Inc (YMI:US) was acquired by GILD:US

Company Profile

3745350 Canada Inc. is developing cancer drugs based on technologies licensed primarily from international academic centers. The Company is currently developing a small molecule chemopotentiator for metastatic breast cancer, an EGFr humanized monoclonal antibody, and a GnRH cancer vaccine. 3745350 Canada is also supporting the preclinical development of additional cancer products.

Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...
sec ||= nil